Sangui Biotech International, Inc. v. Kappes

179 F. Supp. 2d 1240, 2002 U.S. Dist. LEXIS 475, 2002 WL 47097
CourtDistrict Court, D. Colorado
DecidedJanuary 14, 2002
Docket01-B-1424
StatusPublished
Cited by5 cases

This text of 179 F. Supp. 2d 1240 (Sangui Biotech International, Inc. v. Kappes) is published on Counsel Stack Legal Research, covering District Court, D. Colorado primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sangui Biotech International, Inc. v. Kappes, 179 F. Supp. 2d 1240, 2002 U.S. Dist. LEXIS 475, 2002 WL 47097 (D. Colo. 2002).

Opinion

MEMORANDUM, OPINION AND ORDER

BABCOCK, Chief Judge.

Third-party Hermann J. Vohs moves, pursuant to 28 U.S.C. § 1927, for attorney fees and costs from Plaintiff Sangui Bio-tech International Inc.’s (“Sangui’s”) attorneys, Patton Boggs LLP, Jean V. Mac-Harg, Esq., and Robert Bearman, Esq. Specifically, Mr. Vohs requests attorney fees and costs for the period from August 10, 2001, the date he complied with this Court’s July 26, 2001 Temporary Restraining Order (“TRO”), to and including August 15, 2001, the date the Order to Show Cause was discharged. Patton Boggs LLP, Jean MacHarg and Robert Bearman oppose the motion. The motion is adequately briefed and oral argument would not materially aid its determination. For the following reasons, I grant Mr. Vohs’s motion.

I. Background

On July 26, 2001, I issued an ex parte TRO requiring Defendant Kappes and all those acting in concert with him to: (1) refrain from taking any measures in furtherance of Defendant’s illegal exchange offer scheme; and (2) produce to Sangui the names and addresses of all Sangui shareholders known to them. I further ordered that Plaintiffs Motion for Preliminary Injunction be set for an August 6, 2001 hearing.

On August 6, 2001, Defendant Kappes, through counsel, made a special appearance arguing that I lacked jurisdiction to order a preliminary injunction because he had not been served with process as required by Fed.R.Civ.P. 4. Defendant is a resident of the Federal Republic of Germany. In the case of a citizen of the Federal Republic of Germany, service of process may only be acquired under the provisions of the Hague Convention of the Service Abroad of Judicial and Extrajudicial Documents (“Hague Convention”). Because Defendant had not yet been served with process, I did not have jurisdiction to enter a preliminary injunction against him. However, I found good cause to extend the TRO for an additional ten days.

That same day, Sangui filed contempt papers against Mr. Vohs, alleging that he acted in concert with Mr. Kappes and that he had failed to abide by the terms of the TRO by refusing to produce the names and address of all Sangui shareholders known to him. On August 6, 2001, I issued an Order to Show Cause why Mr. Vohs should not be held in contempt (“OSC”) and ordered him to respond by August 15, 2001.

Mr. Vohs has known Defendant Kappes since 1986. Mr. Vohs has been the majority owner and president of Cales Investments, Inc. since 1988. In 1996, Cales Investments entered into a Foreign Distributorship Agreement with a company known as EuroAmerican, which was principally owned by Mr. Kappes. As a result of the Agreement, European shareholders of Sangui opened accounts with Cales Investments.

*1242 Mr. Vohs received a copy of the TRO from Sangui’s counsel, Mr. Bearman, on Friday, July 27, 2001. Upon his receipt of the TRO, Mr. Vohs telephoned Mr. Bear-man and left a message for him. The following Monday, Mr. Vohs sent Mr. Bearman an e-mail asking him “to please respond to ... the question I left on your voice mail last Friday.” Sangui’s Response, Exhibit k- Mr. Vohs and Mr. Bear-man spoke later that day and Mr. Bear-man told Mr. Vohs that he was bound by the TRO. Mr. Vohs informed Mr. Bearman that he did have names and addresses of Sangui shareholders, but that Mr. Kappes had instructed him not to give that information to Sangui. Mr. Vohs “indicated that he would consult with [his] legal counsel and respond to [Mr. Bearman] in a couple of days.” Sangui’s Response, Exhibit k', see also Sangui’s Response, Exhibit 2, Vohs’s Affidavit ¶ 12. A few days later, on August 1, 2001, Mr. Bearman wrote Mr. Vohs a letter confirming their telephone conversation. In the letter, Mr. Bearman wrote:

You informed me that you have in your possession addresses of Sangui shareholders that have been withheld from Sangufs transfer agent by Mr. Kappes and Euro-American Securities. I asked you to provide those addresses to me as Sangui’s attorney immediately. You refused and stated that Mr. Kappes had instructed you to not provide that information to Sangui.
We urge you again to provide to us immediately the names and addresses of the Sangui shareholders that are in you possession, custody or control. If you fail to do so, you may be deemed in contempt of the Order of the Court and subject to severe consequences.

Sangui’s Response, Exhibit 6.

On August 6, 2001, Sangui filed a motion for an order to show cause why Mr. Vohs should not be held in contempt. Attached to the motion was an affidavit of Mr. Bear-man, in which he stated:

4. I sent a copy of this Court’s Temporary Restraining Order (“TRO”) to Mr. Vohs on the day it was issued and spoke with Mr. Vohs by telephone on July 30, 2001.
5. I informed Mr. Vohs that I was one of the attorneys for Sangui.
6. Mr. Vohs confirmed that he had received the Court’s TRO.
7. Mr. Vohs admitted that he has in his control addresses of Sangui shareholders that have been withheld from Sangui’s transfer agent.
8. Mr. Vohs refused to deliver that information to me.

Motion for Order to Show Cause, Bear-man Affidavit ¶ 4-8. Based on the information in Mr. Bearman’s affidavit, I issued an OSC why Mr. Vohs should not be held in contempt.

On Friday, August 10, 2001, Mr. Vohs’s counsel delivered a shareholder list to San-gui. The cover letter from Mr. Vohs’s counsel stated that “Mr. Vohs will cooperate fully with you in explaining the mechanics of preparing this list.” Mr. Vohs’s Motion, Exhibit 2A. The shareholder list was accompanied by a letter from Ms. Vohs stating that he had “no way of ascertaining what status former customers have with regards to share ownership in Sangui Biotech International, Inc. It could be that they transferred or sold their shares or that the address is no longer current.” See id. On August 13, Mr. Vohs filed his Response to the OSC and he filed a short supplemental brief the next morning. In his Responses, Mr. Vohs denied having acted in concert with Mr. Kappes but stated that he nonetheless fully complied with the TRO by supplying the names and ad *1243 dresses of all Sangui shareholders known to him as of July 26, 2001.

On August 14, Sangui’s counsel, Ms. MacHarg telephoned Mr. Vohs’s counsel and asked if he and Mr. Vohs intended to appear at the hearing scheduled the next day. Ms. MacHarg proposed that if Mr. Vohs was to cooperate fully with Sangui, then Sangui would withdraw its contempt motion. Ms. MacHarg wrote a formal letter explaining her offer. The letter stated:

We have proposed an agreement pursuant to which Sangui would withdraw its pending motion to hold Mr. Vohs in contempt in [sic] the Court’s July 26, 2001 TRO in exchange for Mr. Vohs’ cooperation with Sangui by providing us with full and candid information concerning (a) the shareholder list that Mr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
179 F. Supp. 2d 1240, 2002 U.S. Dist. LEXIS 475, 2002 WL 47097, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sangui-biotech-international-inc-v-kappes-cod-2002.